Reptides

Peptides now have their own ETF. According to REX Shares, its new REX Peptide ETF launched today, October 14, on Nasdaq under $PEPT. The company describes it as the first U.S.-listed pure-play peptide ETF. The idea is to give investors exposure to the broader peptide industry, rather than betting on a single drug or company. And it goes beyond GLP-1s. The fund covers: - Companies developing peptide medicines. - Manufacturers and delivery technologies behind those medicines. - Businesses using peptides in supplements and skincare. Its published holdings include Eli Lilly ($LLY), Novo Nordisk ($NVO), Viking Therapeutics ($VKTX), Protagonist Therapeutics ($PTGX), and peptide manufacturer Bachem. So this is not just about which weight-loss drug wins. It also includes the companies making and delivering peptide products. The fund lists 34 holdings and an annual expense ratio of 0.65%.

BREAKING: According to Bloomberg Law, Eli Lilly ($LLY) continues its lawsuit rampage, filing five more cases today over alleged sales and promotion of unapproved retatrutide. The new defendants include three RUO suppliers and two clinic businesses: - American Peptides: Shreveport, Louisiana. RUO supplier. - LiveWell Peptides: Dallas, Texas. RUO supplier offering wholesale and private-label services. - Cenexa Labs: Describes itself as Texas-based, with a Wyoming contact address. RUO supplier. - Medrein Health & Aesthetics: Southlake, Texas. Physician-led medical spa and weight-loss clinic. - MedShape Weight Loss Clinic: Arizona and Minnesota clinics, plus telehealth. Advertises retatrutide as "G3" and claims pharmacy sourcing. August's six cases were concentrated in Texas, with California's Aesthetic Envy as the exception. This latest round expands the geographic reach to businesses operating in Louisiana, Arizona and Minnesota. The August cases targeted: - Legendary Peptides: RUO supplier. - Lone Star Peptide: RUO supplier. - Texas Peptides: RUO supplier. - Astra Peptides: RUO seller. Case continues; unrelated transportation business Astra LLC (dismissed) was removed as a defendant. - Striker Pharmacy: Compounding pharmacy. - Aesthetic Envy: California medical spa (dismissed). 11 lawsuits filed, one case dismissed in full, and 10 still pending based on available public records.

Anadrol and Masteron both came out of Mexican yams. Russell Marker figured out how to chemically degrade diosgenin (the compound in wild yam) into progesterone. Progesterone was $80/g in 1943. About $2/g by the end of the decade. Before that the first isolation was sow ovaries, milligram yields. He set up in Mexico City, cofounded Syntex in 1944. By the late 40s they were the biggest supplier of testosterone, progesterone and estrogens. Ringold's group there wrote up oxymetholone and drostanolone in 1959. Both on the market by the early 60s (Anadrol and Masteron). Same lab, Miramontes had synthesized norethindrone in 1951 under Djerassi. One of the first oral contraceptives. Also 17α-ethynyl-19-nortestosterone, a nandrolone derivative. Wild yam is still sold as a "natural hormone precursor".

Introducing: Peptide education made simple - The GLP Class of Drugs One of the hardest problems to solve in this space is how to transcend the biohacking sphere and enter the meta of peptide education for the masses. Sue from soccer practice doesn't want to get shredded... she just wants her figure from high school back. But how is she supposed to learn about peptides online when most education sites are geared towards the gym/biohacking space? We are making an effort to educate the average person on the positive and negative effects of peptides without having needing a degree in biology.